Godrej Consumer Products shares: Buy, sell or hold after Q4 update?

Godrej Consumer Products shares: Macquarie has maintained an “Outperform” rating with a target of Rs 1,340. It noted strong India performance but flagged weak international business as a near-term drag.
Godrej Consumer Products shares: Buy, sell or hold after Q4 update?
Godrej Consumer Products shares: Buy, sell or hold after Q4 update?

Shares of Godrej Consumer Products Limited will remain in focus in Tuesday’s session after the company outlined its Q4 FY26 business outlook and growth expectations.

The stock settled at Rs 1,001.95 on the NSE in the previous session, up 0.72 per cent. However, the broader trend remains weak. The stock has declined around 10 per cent over the past one month, and is down 19 per cent so far in 2026.

It touched a 52-week high of Rs 1,309.70 in September 2025 and a low of Rs 967.05 in April 2026. The company currently has a market capitalisation of around Rs 1.02 lakh crore.

Add Zee Business as a Preferred Source

Q4 outlook: steady growth, margins stable

In a regulatory filing dated April 6, the company said it expects near double-digit consolidated revenue growth in Q4 FY26. EBITDA growth is also likely to track revenue.

Standalone business is expected to report double-digit sales growth and high single-digit volume growth. Except soaps, most categories are likely to deliver double-digit volume expansion.

The company said growth remains broad-based across categories. Margins are expected to stay within the normal range, supported by cost-saving measures.

Demand trends and inflation outlook

The company flagged that domestic demand conditions remained steady during the quarter. Consumer sentiment improved due to easing food inflation and normalisation in trade channels after GST-related disruptions.

However, rising crude oil prices in the latter part of the quarter have created cost pressures. The company said it is closely monitoring the situation and has already taken steps to manage input costs.

It expects inflation to remain elevated in the first half of FY27. To counter this, the company plans a mix of pricing actions and cost-efficiency measures.

Management added that even if cost pressures persist, it expects to stay broadly in line with its original FY27 bottom-line plans.

Global business: mixed signals

The India business continues to show healthy and broad-based growth.

Indonesia operations are stabilising, with competitive intensity easing. The company expects mid single-digit volume growth and continued market share gains.

The GAUM (Godrej Africa, USA, and Middle East) business remains strong. It is delivering double-digit sales growth along with high single-digit volume expansion.

Brokerage view: targets remain optimistic

Global brokerages remain largely positive on the stock, even as they flag near-term risks.

  • Macquarie has maintained an “Outperform” rating with a target of Rs 1,340. It noted strong India performance but flagged weak international business as a near-term drag.
  • Citi has retained a “Buy” rating with a target of Rs 1,425. It highlighted strong growth momentum and said the company has adequate levers to manage inflation. The brokerage also named it among its top picks in the sector.
  • Morgan Stanley maintained a “Buy” rating with a target of Rs 1,159. It said Q4 performance is broadly in line, with India growth strong and Indonesia pressures easing.
  • UBS has also maintained a “Buy” rating, though it cut the target price to Rs 1,350 from Rs 1,550, citing global uncertainties.